Qualigen Therapeutics, Inc.

NasdaqCM:QLGN Stock Report

Market Cap: US$1.8m

Qualigen Therapeutics Balance Sheet Health

Financial Health criteria checks 2/6

Qualigen Therapeutics has a total shareholder equity of $-2.1M and total debt of $1.3M, which brings its debt-to-equity ratio to -61.8%. Its total assets and total liabilities are $2.0M and $4.1M respectively.

Key information

-61.8%

Debt to equity ratio

US$1.30m

Debt

Interest coverage ration/a
CashUS$401.80k
Equity-US$2.10m
Total liabilitiesUS$4.14m
Total assetsUS$2.03m

Recent financial health updates

Can Qualigen Therapeutics (NASDAQ:QLGN) Afford To Invest In Growth?

Mar 08
Can Qualigen Therapeutics (NASDAQ:QLGN) Afford To Invest In Growth?

We're A Little Worried About Qualigen Therapeutics' (NASDAQ:QLGN) Cash Burn Rate

Nov 23
We're A Little Worried About Qualigen Therapeutics' (NASDAQ:QLGN) Cash Burn Rate

Recent updates

Qualigen Therapeutics GAAP EPS of -$0.11 beats by $0.06, revenue of $1.4M beats by $0.05M

Aug 16

Qualigen Therapeutics files mixed shelf offering of up to $150M

Jul 29

Qualigen partners Hande Sciences to support its application enabling studies for QN-302

Jul 06

Can Qualigen Therapeutics (NASDAQ:QLGN) Afford To Invest In Growth?

Mar 08
Can Qualigen Therapeutics (NASDAQ:QLGN) Afford To Invest In Growth?

We're A Little Worried About Qualigen Therapeutics' (NASDAQ:QLGN) Cash Burn Rate

Nov 23
We're A Little Worried About Qualigen Therapeutics' (NASDAQ:QLGN) Cash Burn Rate

Is Qualigen Therapeutics (NASDAQ:QLGN) In A Good Position To Deliver On Growth Plans?

Apr 05
Is Qualigen Therapeutics (NASDAQ:QLGN) In A Good Position To Deliver On Growth Plans?

Qualigen nabs additional U.S. patent for ALAN anticancer platform

Dec 15

Qualigen Therapeutics EPS misses by $0.61, misses on revenue

Nov 13

Financial Position Analysis

Short Term Liabilities: QLGN has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: QLGN has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: QLGN has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: QLGN's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: QLGN has sufficient cash runway for 0 months based on last reported free cash flow, but has since raised additional capital.

Forecast Cash Runway: QLGN is forecast to have sufficient cash runway for 0 months based on free cash flow estimates, but has since raised additional capital.


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.